Clinical trials in Potsdam – page 113

Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.

• Early-stage breast cancer interventions
• HPV-positive oropharyngeal cancer treatments
• Advanced treatment strategies

Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.

Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.

• Actinic keratosis treatments
• Hidradenitis suppurativa therapy
• Plaque psoriasis management

Investigations include both traditional and innovative therapeutic approaches for skin conditions.

Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.

• Relapsing-remitting MS treatments
• Novel therapeutic approaches
• Disease modification strategies

Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.

Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.

• Lipoprotein management
• Cholesterol reduction therapies
• Cardiovascular risk prevention

Trials aim to reduce major cardiovascular events and improve patient outcomes.